Burkitt lymphoma is a highly aggressive form of non-Hodgkin lymphoma characterized by rapid tumor growth. It primarily affects lymphoid tissues, including the lymph nodes of the axilla and upper limb. Accurate coding with ICD-10 Code C83.74 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this serious condition.
ICD-10 Code C83.74 specifically denotes Burkitt lymphoma affecting the lymph nodes of the axilla and upper limb. This aggressive lymphoma is associated with rapid proliferation of B-lymphoid cells. The code is utilized in clinical documentation and billing when diagnosing patients with this specific type of lymphoma, ensuring accurate representation of the patient's condition for treatment and reimbursement purposes.
Burkitt lymphoma is a highly aggressive B-cell non-Hodgkin lymphoma that often presents with rapidly enlarging lymph nodes, particularly in the axillary and upper limb regions. The condition is associated with chromosomal translocations involving the MYC gene, leading to uncontrolled cell proliferation. Prompt diagnosis and treatment are critical due to the aggressive nature of this lymphoma.
ICD-10 Code C83.74 is integral in SOAP notes for documenting the clinical presentation, assessment, and treatment of Burkitt lymphoma. It aids in capturing the patient's symptoms, guiding clinical decision-making, and ensuring appropriate billing in both acute and chronic care settings.
In SOAP notes, ICD-10 Code C83.74 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Burkitt lymphoma. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Burkitt lymphoma requires urgent medical intervention due to its aggressive nature. Treatment typically involves chemotherapy and may necessitate hospitalization for intensive management.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C83.74 is crucial for accurate billing in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push, single or initial substance. |
| 99223 | Initial hospital care, typically 70 minutes or more. |
| 85025 | Complete blood count (CBC) with automated differential white blood cell count. |
Common Questions About Using ICD-10 Code C83.74 for Burkitt lymphoma, lymph nodes of axilla and upper limb
What are the common symptoms of Burkitt lymphoma?
Common symptoms include rapidly enlarging lymph nodes, fever, night sweats, and weight loss. Patients may also experience fatigue and general malaise due to the aggressive nature of the disease.
How is Burkitt lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of affected lymph nodes to confirm the presence of Burkitt lymphoma cells.
What is the treatment for Burkitt lymphoma?
Treatment usually consists of intensive chemotherapy regimens, which may require hospitalization due to the aggressive nature of the disease and potential complications.
How does ICD-10 Code C83.74 affect billing?
ICD-10 Code C83.74 is essential for accurate billing, as it specifies the diagnosis of Burkitt lymphoma affecting the lymph nodes of the axilla and upper limb, ensuring proper reimbursement for treatment provided.
Clinical Notes
SOAP notes
DAP notes
AI medical notes